Blog from IFPMA ADG Greg Perry following his visit to Cabo Verde
Find out here an insight that Greg Perry gives around WHO Afro Global Health Forum 2019
Read More
Thought Leader Series in Vaccines
A mustread from experts talking about the value of vaccines
Read More
Our response to Zika virus
Check here about the R&D blueprint against Zika
Read More
Women’s Cancer Initiative in the Americas
Partnership to improve prevention of women’s cancers and quality of cancer registries in LAC reaches 1 year milestone
Read More
Latest News
2021-12-16 11:41:08
11 billion COVID-19 vaccines produced in 2021 has resulted in the biggest immunization campaign in human history and 2022 will require more and better vaccine redistribution and innovation
A year since the first COVID-19 vaccine was administered, vaccine makers including biotechnology firms, developing and developed country manufacturers say ...
Read More2021-12-03 15:07:32
Global pharmaceutical industry leaders meet with UK Prime Minister to discuss leadership in global health and innovation
London, 3 December, 2021 – Yesterday, global leaders from the pharmaceutical industry met with the ...
Read More2021-11-17 08:00:16
20 leading research, medical and pharmaceutical organizations call on G7 to step up action to strengthen the R&D antibiotic pipeline
November 17, 2021, Berlin – Ahead of the “World Antimicrobial Awareness Week” (November 18-24) 20 national ...
Read More2021-10-25 10:47:48
Bolstering action against future pandemics: pharma policy perspectives on delivering medical countermeasures
Future pandemic preparedness discussions cannot and must not overshadow the need for urgent joint action ...
Read More2021-10-19 08:22:17
As COVID-19 vaccine output estimated to reach over 12 billion by year end and 24 billion by mid-2022, innovative vaccine manufacturers renew commitment to support G20 efforts to address remaining barriers to equitable access
This month, COVID-19 vaccine manufacturing output will pass the 9.3 billion dose mark. The biopharmaceutical ...
Read More2021-09-28 12:28:43
African research foundation partners with international pharmaceutical industry to strengthen capacity for health innovation in Africa
28 September 2021, Cape Town/Geneva – H3D-Foundation (H3D-F) and the International Federation of Pharmaceutical Manufacturers ...
Read More2021-09-16 11:58:09
Meet Africa’s New Generation of Health Innovators
Dakar, Senegal, 16 September 2021– The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) ...
Read More
Latest Statement
2021-12-03 16:30:55
Global biopharmaceutical industry early response to Omicron
3 December 2021 – COVID-19, the worst pandemic the world has seen in 100 years, has shown us that we ...
Read More2021-12-03 10:16:37
Joint Statement on Patient Solidarity Day
Dakar, Senegal, 16 September 2021– The International Federation of ...
Read More2021-12-03 09:35:01
Biopharmaceutical industry collaborates on the implementation of the G7 100 Days Mission to improve readiness for future pandemics
Dakar, Senegal, 16 September 2021– The International Federation of ...
Read More2021-11-26 15:00:04
The European Commission and Innovative Biopharmaceutical Industries to Explore Potential Initiatives to Enhance Local Production of Vaccines and Treatments in Africa
Dakar, Senegal, 16 September 2021– The International Federation of ...
Read More2021-11-24 14:22:01
IFPMA Statement - Special Session of World Health Assembly on Pandemic Treaty
Dakar, Senegal, 16 September 2021– The International Federation of ...
Read More2021-11-24 11:00:21
Joint Statement on World Antimicrobial Awareness Week
Dakar, Senegal, 16 September 2021– The International Federation of ...
Read More2021-11-17 16:06:10
Pharmaceutical industry reacts to WHO report on access to insulin highlighting shared goals and divergent views
Dakar, Senegal, 16 September 2021– The International Federation of ...
Read More
mailto:a.jones@ifpma.org
Abigail Jones - Director, Communications
Abigail Jones is responsible for communications at IFPMA. She joined IFPMA after over 25 years in international communications and public affairs consultancy, where she worked for many blue-chip companies, trade associations, think tanks, coalition and advocacy groups. Abigail supported the launches and ongoing work of the Fight the Fakes campaign, AMR Industry Alliance and Pat-INFORMED.
mailto:m.depol@ifpma.org
Twitter @MorganePol
Morgane De Pol - Deputy Director, Communications
Morgane develops and implements public affairs programs that build trust, dialogue and collaboration between the innovative biopharmaceutical industry and other global players in the health community. Morgane has international experience in developing and rolling-out integrated advocacy and communications strategies in the global health sector, with specific focus on institutional communications, media relations, alliance building and event management.
Our Brouchure
2015 Edition
A shared commitment to global health
At IFPMA we advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.
Our Logo
Full colour EPS format
Our Logo
Full colour PNG format
FULL Name LOGO
Full colour EPS format
FULL Name LOGO
Full colour PNG format
News Release
Meeting discusses COVID-19 vaccine manufacturing bottlenecks that must be urgently tackled for C19 vaccine output to reach its full potential
9 March 2021: Chatham House, in collaboration with COVAX, IFPMA, DVCMN, and BIO, convened a Global COVID-19 Vaccine Supply Chain & Manufacturing Summit on 8th and 9th March. The unprecedented scaling up of vaccine manufacturing, from zero to billions of
Read MoreOur Blog
How far we have come and how far we have yet to go
Against the backdrop of increasing concerns around Omicron, last week we convened a media briefing on the biopharmaceutical industry’s efforts over the past year since the first COVID-19 vaccine was administered. This was a unique opportunity to share insights from the Biotechnology Innovation Organization (BIO) and the Developing Countries Vaccine Manufacturers’ Network (DCVMN) and the IFPMA. These three trade groups represent most of the major players in...
Read More
Leveling the playing field for women in science and technology innovation in Africa
Innovation is crucial to identifying solutions to Africa’s healthcare needs. However, without the participation of women in the fields of Science, Technology, Engineering, and Mathematics (STEM), Africa and the world is bound to miss their invaluable perspectives and critical contributions. Women account for 30 percent of Sub-Saharan Africa's researchers and innovators and face limited access to funding and skills gaps that are key to business...
Read More
It's time to put an end to pathogen protectionism
This op-ed was originally published for Swissinfo on 16 December 2021. Thomas Cueni, Director General of the International Federation of Pharmaceutical Manufacturers and Associations, calls for unrestricted access to pathogen sharing to help the world prepare for new variants and future pandemics. Before the Covid-19 pandemic, only experts knew what “genome sequencing” meant. This changed when scientists in China swiftly shared the SARS CoV-2 genome...
Read MoreLatest Tweets
